Literature DB >> 25908229

Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis.

Binit Sureka1, Kalpana Bansal1, Yashwant Patidar1, S Rajesh1, Amar Mukund1, Ankur Arora2.   

Abstract

The normal functioning of brain is intimately as well as intricately interrelated with normal functioning of the liver. Liver plays a critical role of not only providing vital nutrients to the brain but also of detoxifying the splanchnic blood. Compromised liver function leads to insufficient detoxification thus allowing neurotoxins (such as ammonia, manganese, and other chemicals) to enter the cerebral circulation. In addition, portosystemic shunts, which are common accompaniments of advanced liver disease, facilitate free passage of neurotoxins into the cerebral circulation. The problem is compounded further by additional variables such as gastrointestinal tract bleeding, malnutrition, and concurrent renal failure, which are often associated with liver cirrhosis. Neurologic damage in chronic liver disease and liver cirrhosis seems to be multifactorial primarily attributable to the following: brain accumulation of ammonia, manganese, and lactate; altered permeability of the blood-brain barrier; recruitment of monocytes after microglial activation; and neuroinflammation, that is, direct effects of circulating systemic proinflammatory cytokines such as tumor necrosis factor, IL-1β, and IL-6. Radiologist should be aware of the conundrum of neurologic complications that can be encountered in liver disease, which include hepatic encephalopathy, hepatocerebral degeneration, hepatic myelopathy, cirrhosis-related parkinsonism, cerebral infections, hemorrhage, and osmotic demyelination. In addition, neurologic complications can be exclusive to certain disorders, for example, Wilson disease, alcoholism (Wernicke encephalopathy, alcoholic cerebellar degeneration, Marchiafava-Bignami disease, etc). Radiologist should be aware of their varied clinical presentation and radiological appearances as the diagnosis is not always straightforward.
Copyright © 2015 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25908229     DOI: 10.1067/j.cpradiol.2015.03.004

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  10 in total

Review 1.  Management of Neurologic Manifestations in Patients with Liver Disease.

Authors:  José M Ferro; Pedro Viana; Patrícia Santos
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.598

Review 2.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

3.  Study on Mechanism of Iridoid Glycosides Derivatives from Fructus Gardeniae in Jiangxi Province by Network Pharmacology.

Authors:  Fangzhou Liu; Yuanbai Li; Meng Li; Jing Wang; Yiying Zhang; Yu Du; Yang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-26       Impact factor: 2.629

4.  Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis.

Authors:  Kosuke Kaji; Kiwamu Okita; Kazuyuki Suzuki; Ikuya Sato; Masaki Fujisawa; Hitoshi Yoshiji
Journal:  JGH Open       Date:  2020-12-07

5.  Hepatic transcriptome and DNA methylation patterns following perinatal and chronic BPS exposure in male mice.

Authors:  Axelle Brulport; Daniel Vaiman; Elias Bou-Maroun; Marie-Christine Chagnon; Ludovic Le Corre
Journal:  BMC Genomics       Date:  2020-12-09       Impact factor: 3.969

6.  Leveraging genomic diversity for discovery in an electronic health record linked biobank: the UCLA ATLAS Community Health Initiative.

Authors:  Ruth Johnson; Yi Ding; Vidhya Venkateswaran; Arjun Bhattacharya; Kristin Boulier; Alec Chiu; Sergey Knyazev; Tommer Schwarz; Malika Freund; Lingyu Zhan; Kathryn S Burch; Christa Caggiano; Brian Hill; Nadav Rakocz; Brunilda Balliu; Christopher T Denny; Jae Hoon Sul; Noah Zaitlen; Valerie A Arboleda; Eran Halperin; Sriram Sankararaman; Manish J Butte; Clara Lajonchere; Daniel H Geschwind; Bogdan Pasaniuc
Journal:  Genome Med       Date:  2022-09-09       Impact factor: 15.266

7.  Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

Authors:  Natalie M Zahr; Kilian M Pohl; Allison J Kwong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 6.208

8.  Multiplex Immunoassay of Plasma Cytokine Levels in Men with Alcoholism and the Relationship to Psychiatric Assessments.

Authors:  Ann M Manzardo; Albert B Poje; Elizabeth C Penick; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

9.  Chronic HCV infection and neuropsychiatric dysfunction.

Authors:  Ida Fortini; Eustáquio Martins Gomes Arouca; Fatima Mitiko Tengam; Ricardo Nitrini
Journal:  eNeurologicalSci       Date:  2019-09-05

10.  Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage.

Authors:  Shandiz Morega; Bogdan Cătălin; Cristiana Eugenia Simionescu; Konstantinos Sapalidis; Ion Rogoveanu
Journal:  Brain Sci       Date:  2021-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.